Mammary stem and progenitor cells are essential for mammary gland homeostasis and are also candidates for cells of origin of mammary tumors. Here, we have investigated the function of the protein kinase p38a in the mammary gland using mice that delete this protein in the luminal epithelial cells. We show that p38a regulates the fate of luminal progenitor cells through modulation of the transcription factor RUNX1, an important controller of the estrogen receptor-positive cell lineage. We also provide evidence that the regulation of RUNX1 by p38a probably involves the kinase MSK1, which phosphorylates histone H3 at the RUNX1 promoter. Moreover, using a mouse model for breast cancer initiated by luminal cells, we show that p38a downregulation in mammary epithelial cells reduces tumor burden, which correlates with decreased numbers of tumor-initiating cells. Collectively, our results define a key role for p38a in luminal progenitor cell fate that affects mammary tumor formation.
INTRODUCTION
The mammary gland is a complex organ that undergoes constant remodeling during the different developmental stages (Hennighausen and Robinson, 2005) . During the last decade, we have learned about the composition and cellular hierarchy of the mammary epithelium. Mammary stem cells give rise to three major cellular lineages: estrogen receptor (ER) + cells and ER À or milk-secreting cells in the luminal compartment, and myoepithelial cells in the basal compartment (Giraddi et al., 2015; Rodilla et al., 2015; Van Keymeulen et al., 2011) . The regulatory network that orchestrates the lineage specification and differentiation of the mammary epithelial cells is not fully understood. Given that stem and progenitor cells are strong candidates for cells of origin of cancer, the identification of regulatory components is crucial to improving our understanding of the mechanism that underlies breast cancer (Visvader, 2011) . The protein kinase p38a has been implicated in the control of tissue homeostasis in various organs. There is evidence that p38a signaling in mammalian epithelial cells can inhibit proliferation and induce differentiation (Cuadrado and Nebreda, 2010) . A possible role for p38a in the regulation of mammary morphogenesis has been proposed, based on the treatment of established cell lines with SB203580, a compound that inhibits p38a and the related kinase p38b, as well as in the analysis of genetically modified mice that are deficient for the p38a activators MKK3 and MMK6 (Wen et al., 2011) . Furthermore, p38a has been implicated in the regulation of stem cell proliferation and differentiation in lung and the hematopoietic system (Karigane et al., 2016; Ventura et al., 2007) . Several reports using p38a-deficient mice have also revealed that p38a can function as a tumor suppressor in lung, liver, and colon (Gupta et al., 2014; Hui et al., 2007; Ventura et al., 2007) . Moreover, the use of SB203580 or the genetic modification of p38a regulators, such as MKK3, MKK6, or the Wip1/PPM1D phosphatase, have provided evidence that p38a in mammary epithelial cells can suppress tumor initiation (Bulavin et al., 2004; Demidov et al., 2007; Wen et al., 2011) . On the other hand, tumors induced by the expression of polyoma middle T antigen (PyMT) in the mouse mammary epithelia, which are initiated by luminal cells, seem to rely on p38a for normal growth based on results using chemical inhibitors (Pereira et al., 2013) .
We have used mice that delete p38a in the luminal cell compartment to investigate the function of p38a in the mammary gland. We found that p38a deficiency reduces the number of mammary progenitor cells and the ER + cell lineage. Moreover, these mice show reduced mammary tumorigenesis induced by PyMT expression, which correlates with a decreased pool of tumor-initiating cells (TICs).
RESULTS

p38a Regulates Mammary Luminal Progenitor Cells in Homeostasis
To study the role of p38a in mammary gland homeostasis, we crossed animals carrying a conditional allele of p38a (p38a (lox/lox) ) (Heinrichsdorff et al., 2008; Ventura et al., 2007) with transgenic mice expressing Cre under control of the mouse mammary tumor virus (MMTV) promoter (Wagner et al., 2001) . The p38a (lox/lox) ;MMTV-Cre mice showed downregulation of p38a in the epithelium of the Stem Cell Reports j Vol. 10 j 257-271 j January 9, 2018 j ª 2017 The Author(s). 257 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). mammary gland ( Figure 1A) . To investigate the effect of p38a depletion on the cellular composition of the mammary gland (Visvader and Stingl, 2014) (Prater et al., 2013 ) from p38a (lox/lox) ;MMTV-Cre and control MMTV-Cre virgin female mice ( Figure 1B ). We observed a reduction in the absolute number of luminal cells in p38a-deficient mammary glands ( Figure 1C ). In contrast, the absolute number of basal cells was increased in p38a-deficient mammary glands ( Figure 1C ). We detected p38a mRNA expression in both cell populations, with higher levels in basal cells ( Figure 1D ). However, whereas MMTV-Cre expression resulted in efficient downregulation of p38a in luminal cells, as determined by both genomic analysis of the floxed p38a exon2 and the levels of p38a mRNA, downregulation of p38a in basal cells appeared to be rather mild (Figures 1E and 1F) . These observations suggest that the increased number of basal cells in p38a-deficient mammary glands is probably a consequence of the p38a depletion in luminal cells. Next, we explored the role of p38a during mammary gland development. Whole-mount analysis of mammary glands from p38a (lox/lox) ;MMTV-Cre pubertal females showed a slight delay in ductal tree expansion compared with MMTV-Cre controls, although no obvious gross morphological abnormalities were observed in virgin females ( Figure S1A ). However, lactation glands from p38a (lox/lox) ;MMTV-Cre dams were histologically different from the MMTV-Cre controls, showing a flattened appearance with reduced numbers of alveolar cells and of milk globules in the alveoli ( Figure S1B ). The reduced number of alveolar cells correlated with decreased staining for both the luminal marker Keratin8 and phosphorylated (active) STAT5, a marker of early lactation (Liu et al., 1995) (Figures S1C and S1D) , suggesting that p38a downregulation delays expansion of alveolar cells. However, despite these changes, pups from p38a
;MMTV-Cre females survived ( Figure S1E ), indicating that p38a-deficient mammary glands were able to produce enough milk to support the progeny. The observation that p38a downregulation reduced the luminal cell population of the mammary epithelium (Figures 1B and 1C) prompted us to explore in more detail the role of p38a in these cells. Colony-formation assays using Matrigel cultures revealed a dramatic reduction in the number and size of colonies formed by sorted luminal cells from p38a (lox/lox) ;MMTV-Cre mice compared with MMTV-Cre controls (Figures 2A and S2) . The ability to form colonies has been associated with the numbers of CD61 + luminal progenitor cells (Asselin-Labat et al., 2007) . Indeed, using a combination of CD61 and CD49f antibodies, a significant reduction in the percentage of CD61 + luminal progenitor cells was detected in p38a-deficient luminal epithelial cells ( Figure 2B ). We detected p38a mRNA expression in both luminal progenitor and non-progenitor cells, with higher levels in non-progenitor cells, and both cell populations showed comparable levels of p38a mRNA depletion in p38a (lox/lox) ;MMTV-Cre mice ( Figures 2C and 2D ). CD61 marks both alveolar and ductal progenitor cells, and to discriminate the progenitor cell population that was affected by p38a deletion, we examined the alveolar progenitor marker ALDH1A3 (Giraddi et al., 2015) . Quantification of the stainings indicated no differences in the number of alveolar progenitor cells between p38a (lox/lox) ;MMTV-Cre and the MMTV-Cre control females at estrus stage ( Figure 2E ). However, we detected increased apoptosis by TUNEL staining in the p38a-deficient mammary epithelium during early pregnancy ( Figure 2F ). Further analysis of the mammary luminal cell compartment using previously described Sca1 and CD49b markers (Shehata et al., 2012) Figure 3A ). In addition, we (E) Genomic DNA was purified from luminal and basal cell populations separated as in (B) from the indicated mice and analyzed by qPCR with primers specific for exon 2 and exon 12 (as a control) of the p38a gene. The relative amount of exon 2 versus exon 12 in cells from MMTV-Cre mice was given the value of 1 (n = 3 animals). **p % 0.005; ns, non-significant. (F) Relative expression of the p38a mRNA in luminal and basal cell populations separated as in (B) from the indicated mice was determined by qRT-PCR (n = 3 animals). The expression levels in cells from MMTV-Cre were given the value of 1. **p % 0.005; ns, non-significant. See also Figure S1 . detected substantially higher p38a mRNA expression levels in ER + cells than in ER À cells ( Figure 3B ), whereas p38a depletion was similar in both ER + and ER À cell lineages from p38a (lox/lox) ;MMTV-Cre mice ( Figure 3C ). Moreover, ER and Keratin5 immunostaining confirmed a reduced number of ER + cells and increased number of basal cells (Keratin5 + ) in the p38a-deficient mammary epithelium ( Figure 3D ). Taken together, these results indicate that p38a downregulation in luminal epithelial cells reduces the number of ductal progenitor cells, which probably undergo apoptosis, impairing the mature ductal lineage and interfering with the expansion of alveolar progenitor cells during early pregnancy stages. ( Kendrick et al., 2008; Lim et al., 2010) . We observed that genes overexpressed in p38a-deficient cells showed an enrichment in genes downregulated in mature luminal cells and an enrichment of the luminal progenitor cell gene signature (Figures 4A and S3) , indicating that p38a is required for the maintenance of mature luminal cells. We also found that the transcriptional program of p38a-deficient luminal cells was most similar to ER À characteristics, suggesting the loss of ER + features ( Figure S3 ), which is consistent with our fluorescence-activated cell sorting (FACS) and immunostaining analysis ( Figures 3A and 3D ). We analyzed by qRT-PCR the expression of several genes implicated in the maintenance and specification of luminal cells of the mammary gland ( Figure 4B ). We observed that p38a-deficient luminal cells expressed reduced levels of AKT1, which has been implicated in lactogenic differentiation (Maroulakou et al., 2008) and could contribute to the alveolar compartment phenotype observed during late pregnancy in p38a
(lox/lox) ;MMTV-Cre mice (Figures S1B-S1D). We also observed enhanced expression of markers such as CD14, LALBA, LMOA, and MFGE8 (Shehata et al., 2012) , which correlated with the increased numbers of ER À cells detected. On the contrary, several luminal-specific genes, such as FOXA1, NOTCH3, and WNT4, were downregulated in p38a-deficient luminal cells. The transcription factor FOXA1 is essential for ER expression and function (Bernardo et al., 2010) , whereas NOTCH3 has been implicated in maintenance of the ER (Lim et al., 2010) . Hits mark the position of genes in the published signatures of ML or LP cells according to the fold changes in the p38a null cells from UP (left) to DOWN (right). (B) Genes known to play a role in luminal cell linage specification and maintenance were analyzed by qRT-PCR in luminal cells isolated from mammary glands of mice with the indicated genotypes (n = 3 independent experiments). Values refer to the expression level of each gene in cells from MMTV-Cre mice, which was given the value of 1. *p % 0.05; **p % 0.005; ***p % 0.0005; ****p % 0.00005.
(legend continued on next page) co-localizes with progesterone receptor in the ER + cell lineage present in the ductal epithelium, as it is induced by progesterone during pregnancy (Brisken et al., 2000) . Runt-related transcription factor 1 (RUNX1) is a key regulator of the ER + cell lineage (van Bragt et al., 2014) , and was also downregulated in p38a-deficient luminal cells. On the other hand, RUNX2, which is implicated in alveolar progenitor specification and maturation (Owens et al., 2014) , was upregulated. Of note, the pubertal elongation delay observed in the p38a-depleted mammary glands (Figure S1A ) is very similar to the phenotype reported for mammary glands with RUNX1 loss or RUNX2 overexpression in luminal cells (Owens et al., 2014; van Bragt et al., 2014) .
Further support for a link between RUNX1 and p38a functions was obtained by the significant correlation in the genetic signatures reported for RUNX1-deficient luminal cells (van Bragt et al., 2014) with those of p38a-deficient luminal cells, at the level of both upregulated and downregulated genes ( Figure 4C ). Altogether, it seems likely that p38a regulates the ER + cell lineage, at least in part, through RUNX1 modulation.
p38a Regulates RUNX1 Expression through MSK1-Dependent Chromatin Remodeling Mitogen-and stress-activated protein kinase 1 (MSK1) is a protein kinase regulated by p38a, which has been implicated in the modulation of chromatin marks and can control the expression of genes involved in luminal cell fate (Arthur, 2008; Josefowicz et al., 2016; Reyes et al., 2014; Soloaga et al., 2003; Vermeulen et al., 2009 ). This makes MSK1 a possible candidate to mediate the regulation of RUNX1 by p38a. Previous studies using luminal T47D cells provided evidence for the implication of RUNX1 in the regulation of the ER + program (van Bragt et al., 2014) . We found that T47D cells treated with small interfering RNA (siRNA) against p38a showed impaired MSK1 phosphorylation on sites that are required for its kinase activity (Figure 5A ), which correlated with reduced RUNX1 protein and mRNA levels ( Figures 5A and 5B) . Furthermore, the reduced expression of RUNX1 correlated with decreased ER and FOXA1 mRNA levels ( Figure 5B ), in agreement with previous reports (van Bragt et al., 2014) . Interestingly, analysis of published data obtained using chromatin immunoprecipitation sequencing (ChIP-seq) (Reyes et al., 2014) indicated that MSK1 was recruited to the RUNX1 promoter ( Figure 5C ). MSK1 can phosphorylate histone H3 on Ser10, which in turn may affect chromatin remodeling at large (Josefowicz et al., 2016; Reyes et al., 2014; Soloaga et al., 2003) . Consistent with the detection of MSK1 at the RUNX1 promoter, we observed that T47D cells that are deficient in MSK1 showed reduced levels of Ser10 phosphorylation on histone H3 at the RUNX1 promoter, as determined by ChIP-seq experiments ( Figure 5D ) and further confirmed by ChIP-PCR analysis ( Figure 5E ). The reduced phosphorylation of histone H3-Ser10 at the RUNX1 promoter correlated with decreased RUNX1 mRNA expression levels upon MSK1 depletion ( Figure 5F ). Taken together, these results suggest that p38a depletion results in reduced MSK1 kinase activity, which in turn probably changes the chromatin landscape at the RUNX1 promoter and impairs its transcription. Our results therefore identify p38a as an important modulator of the expression of RUNX1, a gene essential for luminal cell commitment.
p38a Controls the Number of TICs in Mammary Tumors A luminal cell precursor origin has been proposed for the basal-like and luminal subtypes of breast cancer (Visvader and Stingl, 2014) . Therefore, we speculated that the ability of p38a to regulate luminal progenitor cell homeostasis described above might impinge on mammary tumorigenesis. To test this hypothesis, we crossed MMTVPyMT-expressing mice (Guy et al., 1992) with our p38a (lox/lox) ;MMTV-Cre mice to generate p38a (lox/lox) ;
MMTV-Cre;PyMT animals. This is considered a valid model for the study of the multistep progression of mammary tumorigenesis, resembling differentiated human breast cancer of luminal origin (Herschkowitz et al., 2007; Maglione et al., 2001) . We found that genetic deletion of p38a in the PyMT-expressing mammary epithelium reduced mammary tumor burden ( Figure 6A ), which correlated with reduced lung metastasis ( Figure S4A ). Next, we compared cell proliferation and cell death rates in preneoplastic lesions of p38a (lox/lox) ;MMTV-Cre;PyMT and MMTV-Cre;PyMT control animals, and found that p38a downregulation resulted in a decreased numbers of bromodeoxyuridine (BrdU) + cells and increased numbers of TUNEL + cells ( Figure 6B ).
Given the role of p38a in luminal cell maintenance, we investigated whether depletion of p38a might affect the pool of TICs that give rise to mammary tumors. We observed that p38a-deficient luminal cells isolated from pre-neoplastic lesions of p38a (lox/lox) ;MMTV-Cre;PyMT mice showed significantly reduced potential to form tumorspheres compared with the WT luminal cells from (C) GSEA plots showing the correlation between genes upregulated (p38a null UP) or downregulated (p38a null DOWN) in p38a null luminal cells and expression fold changes of the genes in RUNX1 null cells from published data. Hits refer to genes differentially expressed in p38a null cells, which are sorted according to the fold changes in the RUNX1 null cells from UP (left) to DOWN (right). See also Figure S3 .
MMTV-Cre;PyMT mice ( Figures 6C and S4B ). It has been suggested that CD49f and CD61 expression can be used to identify the TICs in different mouse models of mammary tumorigenesis (Lo et al., 2012; Vaillant et al., 2008) , and a cell population enriched in CD61 + cells has been reported to progressively increase in MMTV-PyMT tumors (Kouros-Mehr et al., 2008) . Consistent with the tumorsphere assays, we observed a significant reduction in CD49f + CD61 + cells in the luminal cell population isolated from pre-neoplastic lesions of p38a (lox/lox) ;MMTV-Cre;PyMT mice compared with MMTV-Cre; PyMT controls (Figure 6D) . Furthermore, experiments based on the orthotopic injection of luminal mammary cells isolated from pre-neoplastic lesions showed a significant reduction in tumor-initiating potential of the p38a-deficient cells compared with WT cells (Figures 6E and 6F ). These results indicate that p38a downregulation in luminal cells reduces the number of mammary TICs.
p38a Regulates the Transcriptional Program of Mammary TICs
To investigate the contribution of p38a signaling in luminal cells to mammary TIC maintenance, we analyzed global gene expression changes in WT and p38a-deficient luminal cells isolated from pre-neoplastic lesions. In line with the reduced number of putative TICs observed in mice with p38a-deficient luminal cells, we found that gene sets upregulated in luminal progenitor cells isolated from tumors, which correspond to the cell of origin of PyMT-induced tumors (Lim et al., 2010) , correlated better with the genetic signature of WT luminal cells than that of p38a-deficient luminal cells isolated from pre-neoplastic lesions ( Figure 7A ).
The expression of several genes potentially important for TICs was confirmed by qRT-PCR analysis ( Figure 7B ). In agreement with the delayed tumor progression in p38a (lox/lox) ;MMTV-Cre;PyMT mice, we observed increased expression of ER, which is normally lost during PyMTinduced tumor progression (Lin et al., 2003) . Additionally we observed reduced expression of the transcription factor GATA3, a well-defined marker of luminal breast cancer whose deletion leads to apoptosis and reduced tumor burden in the MMTV-PyMT model (Kouros-Mehr et al., 2008) . The malignant p38a-deficient luminal cells also showed reduced expression of the MET tyrosine kinase receptor, which is highly expressed in aggressive human breast cancer and suffices to induce mammary tumors upon transgenic expression in mice (Gastaldi et al., 2010) . Moreover, MET signaling regulates the growth and fate of luminal progenitor cells (Gastaldi et al., 2013) , and reduced levels of MET correlate with impaired tumorigenesis and decreased numbers of TICs in the MMTV-PyMT model (Gong et al., 2015) . The NOTCH2 and NOTCH3 receptors were also expressed at lower levels in p38a (lox/lox) ;
MMTV-Cre;PyMT luminal cells. There is good evidence that NOTCH signaling is important for breast TICs (Harrison et al., 2010) . In particular, NOTCH2 and NOTCH3 are expressed in the CD61 + luminal progenitor cells that are considered the cell of origin for tumors with constitutive NOTCH activation (Bouras et al., 2008) , and NOTCH3 has been implicated in the survival and self-renewal of human TICs (Sansone et al., 2007) . Finally, we observed reduced expression levels of RUNX1 and RUNX2, which can control mammary tumorigenesis in the MMTV-PyMT model (Browne et al., 2015; Owens et al., 2014) , and have been implicated in human breast cancer (Ito et al., 2015) .
DISCUSSION
Our results identify an important function of p38a in mammary luminal cell homeostasis. We have found p38a expression in both mammary basal and luminal cells, but have not been able to address the role of this signaling pathway in the myoepithelial lineage due to the poor efficiency of deletion observed in our MMTVCre model. The increased number of basal cells observed in p38a deficient mammary glands could be due to paracrine signaling or reflect the conversion of some luminal cells to a basal-like phenotype upon p38a loss; lineagetracing experiments should address these possibilities in the future. We show that p38a downregulation in luminal cells results in reduced ER + cell fate and mature luminal cell specification with enrichment in progenitor cell gene signatures. This conclusion is supported by our gene expression analysis using the entire luminal cell population, which reflects the reduction of the ER + luminal cell lineage observed in p38a null mammary glands, with downregulation of genes that are highly expressed in the ductal lineage but increased expression of genes mainly expressed in progenitor cells. The requirement of p38a to support the ER + cell lineage is consistent with Figure 7 . p38a Regulates the Expression of Genes Implicated in Tumor-Initiating Cell Maintenance and Tumorigenesis (A) GSEA plots showing a negative correlation between the genetic signature of p38a null luminal cells isolated from pre-neoplastic lesions and published signatures of luminal progenitor cells from PyMT-induced tumors (Lim et al., 2010) . Ranked list ordered according to fold changes in the p38a null luminal tumor cells. Hits correspond to the position of genes from the published signatures.
(B) Genes known to play a role in TICs and tumor progression were analyzed by qRT-PCR in luminal cells isolated from mammary preneoplastic lesions of mice with the indicated genotypes (n = 3 independent experiments). Values refer the expression level of each gene in cells from MMTV-Cre;PyMT mice, which was given the value of 1. *p % 0.05; **p % 0.005; ***p % 0.0005; ****p % 0.00005. the higher expression of p38a detected in the ER + cell compartment and the reduction in ER + progenitor cells observed upon p38a downregulation. This p38a function is probably mediated by the transcription factors RUNX1, RUNX2, and FOXA1, which drive the ER program (Bernardo et al., 2010; Owens et al., 2014; van Bragt et al., 2014) . Importantly, the expression profiles of genes associated with the ER + cell lineage are similar in p38a null and RUNX1 null luminal cells, supporting that the reduced Runx1 expression observed in p38a-deficient luminal cells is functionally significant. We also provide evidence indicating that the regulation of RUNX1 by p38a is probably mediated by MSK1, a kinase that can modulate the chromatin landscape though phosphorylation of histone H3 on Ser10 (Josefowicz et al., 2016; Reyes et al., 2014; Soloaga et al., 2003) . Moreover, since FOXA1 and RUNX2 can be both regulated by RUNX1 (van Bragt et al., 2014) , p38a might control the expression of both genes in luminal cells through RUNX1. At the physiological level, misregulation of RUNX1 and RUNX2 probably accounts for the mild defects in pubertal elongation observed in p38a-deficient mammary glands (van Bragt et al., 2014) . Even though the initial number of alveolar progenitor cells does not seem to be affected by p38a deletion in CD61 + luminal progenitor cells, the lactation-induced expansion of the alveolar lineage is affected by a reduction in the lobulo-alveolar epithelium compatible with pup nursing. This might be due to the observed increase in apoptosis during the early events of pregnancy. The increased cell death might be the result of reduced levels of AKT1 observed in p38a-deficient luminal cells (Maroulakou et al., 2008) , contributing to the late pregnancy phenotype present in p38a (lox/lox) ;MMTV-Cre females.
It has been reported that mice treated with SB203580, an inhibitor of p38a and p38b, and MKK3 À/À ;MKK6 +/À mice, which are likely impaired in the activation of all p38 family members, both show defects in mammary lumen anoikis, and increased ductal tree elongation and branching (Wen et al., 2011) . We did not observe these phenotypes upon p38a downregulation in luminal cells, suggesting the requirement for p38a inhibition in other cell populations of the mammary gland, or for combined inhibition of p38a and p38b, which has been shown to result in additional phenotypes in several tissues (del Barco Barrantes et al., 2011; Furlan et al., 2012; Warr et al., 2012) . The analysis of gene expression signatures obtained from different breast cancer subtypes and from several mammary epithelial cell populations has revealed that most breast tumors originate from luminal progenitor cells (Visvader and Stingl, 2014) , which we show are most dependent on p38a signaling. In addition, an alveolar progenitor origin of the PyMT mammary tumors has been described (Tao et al., 2015) . Comparison with previously reported genetic signatures for the cell of origin of PyMT-induced tumors supports a loss of TICs in mammary tumors from mice with p38a-deficient luminal cells. Moreover, p38a-deficient luminal cells exhibit lower tumor-initiating frequency upon orthotopic injection in mice. Our analysis reveals that p38a controls the expression of several genes that support the maintenance or expansion of TICs, such as the receptors MET and NOTCH, and the transcription factors GATA3 and RUNX (Browne et al., 2015; Gastaldi et al., 2013; Gong et al., 2015; Kouros-Mehr et al., 2008; Owens et al., 2014; Sansone et al., 2007) .
Taken together, our data show a fundamental role for p38a in the maintenance of ER + luminal progenitor cells of the mammary gland, most likely through the regulation of RUNX1. The reduced number of ER + luminal progenitor cells might contribute to the decreased mammary tumorigenesis observed in mice with p38a-deficient luminal cells. Of note, the decreased mammary tumorigenesis also correlates with a reduced number of TICs, which may represent an alveolar origin, due to their reduced proliferation and increased apoptosis caused by p38a loss in these cells. Our data reveal that p38a facilitates mammary tumorigenesis by maintaining or expanding the luminal progenitor cell pool.
EXPERIMENTAL PROCEDURES
Mice
Mice p38a (lox/lox) carrying the floxed p38a allele (Heinrichsdorff et al., 2008; Ventura et al., 2007) were bred with MMTV-Cre mice (JAX:003553) that drive Cre expression under the control of the MMTV promoter, and with transgenic mice expressing MMTVPyMT (Guy et al., 1992) . Each line was backcrossed in an FVB/n background for at least ten generations. Mouse genotyping was performed by PCR on genomic tail DNA. Primers and conditions are available upon request. For orthotopic injections, mammary tumor cells were sorted from WT and p38a KO PyMT mice, mixed 1:1 with Matrigel (BD Biosciences #354234), and injected into the mammary fat pad of 6-week-old female nude mice as described in Supplemental Experimental Procedures. Mice were housed following national and European Union regulations, and protocols were approved by the Animal Care and Use Committee of the Barcelona Science Park (CEEA-PCB).
Whole-Mount, Immunohistochemistry, Immunofluorescence, and Image Analysis
Whole mounts of mammary glands were fixed and processed as previously described (Jones et al., 1996) . For histology, immunohistochemistry, and immunofluorescence staining, mammary glands were fixed in 10% neutral buffered formalin solution and embedded in paraffin. Mammary gland sections from virgin females were stained with p38a antibody (Cell Signaling Technology, #9218) 1:50 for 2 hr at room temperature. Mammary gland sections from females at lactation day 0 were stained with H&E or were analyzed by immunofluorescence using antibodies against Keratin8 (DSHB #531826; 1:200, overnight 4 C), a-smooth muscle actin (Sigma, #A5228; 1:5,000, overnight 4 C), and phospho-STAT5 (Cell Signaling, #9314; 1:500, 2 hr at room temperature). Mammary gland sections from females at estrus stage were analyzed by immunofluorescence using antibodies against ER (Leica Biosystems, #6F11; 1:100, 1 hr at room temperature), ALDH1A3 (Sigma, #HPA04627; 1:100, 1 hr at room temperature), and Keratin5 (Abcam, #ab53121; 1:1,000, 1 hr at room temperature ). For cell proliferation analysis, BrdU (Roche, #10280879001) was intraperitoneally injected (1 mg/10 g body weight) in 6-week-old female mice, and 1 hr later the mice were euthanized. Samples were stained with anti-BrdU antibody (BD Biosciences, #347580; 1:100, 1 hr at room temperature). The secondary antibodies used were antimouse (Dako, #P0447; 1:100, 30 min at room temperature) and HRP-conjugated anti-rabbit (ImmunoLogic, #DPVR110HRP, 45 min at room temperature). Apoptosis was quantified by TUNEL using the In Situ Cell Death Detection Kit, AP (Roche, #11684795910) as specified by the manufacturer. Paraffinembedded lung sections from 14-week-old PyMT-expressing female mice were stained with H&E. Bright-field images were acquired with a NanoZoomer-2.0 HT C9600 scanner (Hamamatsu) equipped with a 203 objective. Immunofluorescent images were acquired as before but using an L11724-01 mercury lamp unit. All images were visualized with a gamma correction set at 1.8 in the image control panel of the NDP.view 2 U123888-01 software (Hamamatsu, Photonics, France). Otherwise tissue sections were imaged using the Zeiss confocal microscope LSM780. Image analysis was performed using QuPath, an open-source software for quantitative pathology.
Mammary Gland Cell Preparation, Flow-Cytometry Analysis, and Cell Sorting
Thoracic and inguinal mammary glands were dissected from 9-weekold p38a
(lox/lox)
;MMTV-Cre and MMTV-Cre virgin females or 6-weekold p38a (lox/lox) ;MMTV-Cre;PyMT and MMTV-Cre;PyMT female mice. Cell suspensions were prepared as previously described (Prater et al., 2013) . FACS sorting was performed with a FACSAria sorter (BD Bioscience). Data were analyzed with the FlowJo software package. The antibodies used for FACS were from Miltenyi Biotec: Epcam-APC (#130102234), Epcam-FITC (#130102214), CD49f-APC (#130097250), CD49f-PE (#130097246), BP1-biotin (#130101844), CD31-biotin (#130101955), CD45-biotin (#130101952), and Ter119-biotin (#130101882); and from Biolegend: CD61-AF480 (#104311), Sca1-PECy7 (#108114), CD49b-PE (#103506), and Streptavidin-APCCy7 (#405208). FACS gating was based on single color staining and fluorescence-minus-one controls, and was checked with isotype controls (Prater et al., 2013) . Gating strategies were as described previously (Prater et al., 2013; Shehata et al., 2012) . For colony-formation assays, freshly sorted cells were embedded in Matrigel (BD Pharmingen) as described previously (Shackleton et al., 2006) .
Cell Culture, siRNA Transfection, and Immunoblotting
The human breast cancer cell line T47D was cultured and analyzed as described in Supplemental Experimental Procedures.
Microarray, qPCR, and ChIP-Seq Data Analysis
For microarray analysis, EpCam high CD49f med luminal cell populations were sorted from either normal mammary glands of 9-weekold mice or pre-neoplastic mammary lesions of 6-week-old mice expressing PyMT. RNA purification, microarray processing, qPCR, and ChIP-seq data analysis were performed as described in Supplemental Experimental Procedures.
Statistical Analyses
Data are presented as mean ± SEM. Statistical significance was determined by Student's t test using GraphPad Prism version 6.
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